Table 3.
CHD Incidence | P-value | Stroke Incidence | P-value | CVD Mortality | P-value | All-cause Mortality | P-value | |
---|---|---|---|---|---|---|---|---|
Men | ||||||||
HTN+/DM− | Reference | — | Reference | — | Reference | — | Reference | — |
HTN−/DM+ | 1.13(0.79–1.62) | 0.5 | 1.08(0.57–2.04) | 0.82 | 1.43(0.85–2.39) | 0.18 | 1.72(1.2–2.45) | 0.003 |
HTN+/DM+ | 1.67(1.19–2.34) | 0.003 | 2.14(1.23–3.72) | 0.007 | 3.21(2.03–5.06) | <0.001 | 2.61(1.83–3.71) | <0.001 |
HTN−/DM− | 0.63(0.48–0.82) | 0.001 | 0.29(0.16–0.52) | <0.001 | 0.34(0.21–0.56) | <0.001 | 0.48(0.35–0.66) | <0.001 |
Women | ||||||||
HTN+/DM− | Reference | — | Reference | — | Reference | — | Reference | — |
HTN−/DM+ | 1.28(0.83–1.97) | 0.26 | 1.07(0.4–2.86) | 0.89 | 1.04(0.45–2.41) | 0.92 | 1.28(0.73–2.26) | 0.38 |
HTN+/DM+ | 2.31(1.69–3.15) | <0.001 | 1.28(0.67–2.42) | 0.45 | 1.99(1.20–3.31) | 0.008 | 2.09(1.45–3.01) | <0.001 |
HTN−/DM− | 0.56(0.4–0.79) | 0.001 | 0.85(0.45–1.61) | 0.63 | 0.34(0.16–0.70) | 0.004 | 0.77(0.51–1.16) | 0.21 |
Total Population | ||||||||
HTN+/DM− | Reference | — | Reference | — | Reference | — | Reference | — |
HTN−/DM+ | 1.19(0.9–1.57) | 0.21 | 1.07(0.63–1.82) | 0.8 | 1.28(0.83–1.97) | 0.27 | 1.62(1.2–2.18) | 0.001 |
HTN+/DM+ | 1.96(1.57–2.46) | <0.001 | 1.66(1.1–2.52) | 0.017 | 2.6(1.85–3.65) | <0.001 | 2.32(1.8–2.98) | <0.001 |
HTN−/DM− | 0.61(0.49–0.75) | <0.001 | 0.44(0.29–0.68) | <0.001 | 0.34(0.23–0.51) | <0.001 | 0.57(0.44–0.73) | <0.001 |
*Adjusted for sex (for total population), age, BMI, waist to hip ratio, education level, current smoking, low physical activity, and hypercholesterolemia.
CHD, coronary heart disease; CVD, cardiovascular disease; HTN, hypertension; DM, type 2 diabetes mellitus.
Standard errors were reported as confidence intervals and P-values.